Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TORISEL Cause Metastatic renal cell carcinoma? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Metastatic renal cell carcinoma have been filed in association with TORISEL. This represents 6.4% of all adverse event reports for TORISEL.

5
Reports of Metastatic renal cell carcinoma with TORISEL
6.4%
of all TORISEL reports
2
Deaths
2
Hospitalizations

How Dangerous Is Metastatic renal cell carcinoma From TORISEL?

Of the 5 reports, 2 (40.0%) resulted in death, 2 (40.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.

Is Metastatic renal cell carcinoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TORISEL. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TORISEL Cause?

Disease progression (17) Pleural effusion (5)

What Other Drugs Cause Metastatic renal cell carcinoma?

SUNITINIB MALATE (407) PAZOPANIB (154) AXITINIB (140) EVEROLIMUS (83) CABOZANTINIB S-MALATE (77) NIVOLUMAB (57) TEMSIROLIMUS (37) SUTENT (35) SORAFENIB (30) PREDNISOLONE (23)

Related Pages

TORISEL Full Profile All Metastatic renal cell carcinoma Reports All Drugs Causing Metastatic renal cell carcinoma TORISEL Demographics